IL6 and neoplasm: When inhibiting synthesis of human IL‐6 from PC cells by RNA silencing and inhibition of human IL‐6/gp130 axis by tocilizumab, anti‐IL‐6R antibody, the growth of tumor was suppressed in the N‐inv model.